Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis
Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest...
Gespeichert in:
Veröffentlicht in: | Endocrine pathology 2021-09, Vol.32 (3), p.327-335 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 335 |
---|---|
container_issue | 3 |
container_start_page | 327 |
container_title | Endocrine pathology |
container_volume | 32 |
creator | Boyraz, Baris Sadow, Peter M. Asa, Sylvia L. Dias-Santagata, Dora Nosé, Vania Mete, Ozgur |
description | Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest case series, consisting of 33 tumors. The age at time of pathological diagnosis ranged from 18 to 59 (mean 33) years, and all patients except one were female. Sixteen patients had multifocal and fifteen had unifocal disease. The status of focality was unavailable in two patients. Tumors were well-circumscribed, ranging in size from 0.1 to 8.0 cm. The cribriform component was admixed with morulae in the majority, except seven had a cribriform-predominant architecture and two had predominantly solid growth. Variable degrees of nuclear enlargement, elongation, overlapping, and grooves were seen but florid nuclear convolution, intranuclear pseudoinclusions, and optically clear nuclei due to chromatin margination were not appreciated. There was no or little colloid material within the cribriform spaces. Two solid tumors had high-grade features. Immunohistochemical studies showed beta-catenin nuclear and cytoplasmic positivity in all cases. The cribriform component was positive for TTF1 and negative for thyroglobulin. PAX8 was absent in half of these tumors and focal in the remainder. Morulae were positive for keratin 5 and CD5 and negative for p63, p40, TTF1, and PAX8. Molecular studies revealed germline
APC
mutations in 12 tumors and were negative in 5 sporadic tumors in a subset of tested tumors. Irrespective of the antibody used in this cohort, all cribriform-morular carcinomas express TTF1; however, PAX8 immunoreactivity is weak, focal or negative, and all tumors lack thyroglobulin reactivity; these findings raise questions about tumor cell origin and may indicate that these are not of thyroid follicular epithelial differentiation. We postulate that morulae may represent divergent thymic/ultimobranchial pouch-related differentiation. Given their unique cytomorphology, immunohistochemical profiles, and genetic features that have little overlap with traditional follicular cell-derived thyroid carcinomas, we propose that these tumors represent a distinct form of thyroid carcinoma unrelated to other neoplasms of thyroid follicular cells. |
doi_str_mv | 10.1007/s12022-021-09683-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9353615</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2562078016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-563e26baffbb4c6df6061c5c4d1f9fa848a83dfa705b0cc7b0a6e74189873dcf3</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0Eoj_wAixQJDZsDGM7sZMNEgoUKrXqpt1iTRz71lViFztBum-Pyy0X2kVXY-l8c2bGh5A3DD4wAPUxMw6cU-CMQidbQeEZOWRN01GATj0vb6glFZ2SB-Qo5xsAJgD4S3IgamAdF_KQ_OiTH5J3Mc30PKZ1wlRdXm9T9GPVYzI-xBmr01xh9cXnxQez7PVznPwmYDDbKrrqKhibFvSh6rdL3Nhgs8-vyAuHU7av7-sxuTr5etl_p2cX3077z2fU1KpeaCOF5XJA54ahNnJ0EiQzjalH5jqHbd1iK0aHCpoBjFEDoLSqZm3XKjEaJ47Jp53v7TrMdjQ2LAknfZv8jGmrI3r9UAn-Wm_iL92JRkjWFIP39wYp_lxtXvTss7HThMHGNWveCMbLd6s79N0j9CauKZTzCiU5qBaYLBTfUSbFnJN1-2UY6Lv49C4-XeLTf-LTUJre_n_GvuVvXgUQOyAXKWxs-jf7CdvfxRCnaQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2562078016</pqid></control><display><type>article</type><title>Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Boyraz, Baris ; Sadow, Peter M. ; Asa, Sylvia L. ; Dias-Santagata, Dora ; Nosé, Vania ; Mete, Ozgur</creator><creatorcontrib>Boyraz, Baris ; Sadow, Peter M. ; Asa, Sylvia L. ; Dias-Santagata, Dora ; Nosé, Vania ; Mete, Ozgur</creatorcontrib><description>Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest case series, consisting of 33 tumors. The age at time of pathological diagnosis ranged from 18 to 59 (mean 33) years, and all patients except one were female. Sixteen patients had multifocal and fifteen had unifocal disease. The status of focality was unavailable in two patients. Tumors were well-circumscribed, ranging in size from 0.1 to 8.0 cm. The cribriform component was admixed with morulae in the majority, except seven had a cribriform-predominant architecture and two had predominantly solid growth. Variable degrees of nuclear enlargement, elongation, overlapping, and grooves were seen but florid nuclear convolution, intranuclear pseudoinclusions, and optically clear nuclei due to chromatin margination were not appreciated. There was no or little colloid material within the cribriform spaces. Two solid tumors had high-grade features. Immunohistochemical studies showed beta-catenin nuclear and cytoplasmic positivity in all cases. The cribriform component was positive for TTF1 and negative for thyroglobulin. PAX8 was absent in half of these tumors and focal in the remainder. Morulae were positive for keratin 5 and CD5 and negative for p63, p40, TTF1, and PAX8. Molecular studies revealed germline
APC
mutations in 12 tumors and were negative in 5 sporadic tumors in a subset of tested tumors. Irrespective of the antibody used in this cohort, all cribriform-morular carcinomas express TTF1; however, PAX8 immunoreactivity is weak, focal or negative, and all tumors lack thyroglobulin reactivity; these findings raise questions about tumor cell origin and may indicate that these are not of thyroid follicular epithelial differentiation. We postulate that morulae may represent divergent thymic/ultimobranchial pouch-related differentiation. Given their unique cytomorphology, immunohistochemical profiles, and genetic features that have little overlap with traditional follicular cell-derived thyroid carcinomas, we propose that these tumors represent a distinct form of thyroid carcinoma unrelated to other neoplasms of thyroid follicular cells.</description><identifier>ISSN: 1046-3976</identifier><identifier>EISSN: 1559-0097</identifier><identifier>DOI: 10.1007/s12022-021-09683-0</identifier><identifier>PMID: 34019236</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adenocarcinoma - pathology ; Adenomatous polyposis coli ; Adolescent ; Adult ; CD5 antigen ; Chromatin ; Endocrinology ; Female ; Humans ; Immunoreactivity ; Keratin ; Male ; Malignancy ; Medicine ; Medicine & Public Health ; Middle Aged ; Neoplasia ; Oncology ; Papillary thyroid carcinoma ; Pathology ; Pax8 protein ; Solid tumors ; Thymus ; Thyrocytes ; Thyroglobulin ; Thyroid ; Thyroid cancer ; Thyroid Neoplasms - pathology ; Tumors ; Young Adult ; β-Catenin</subject><ispartof>Endocrine pathology, 2021-09, Vol.32 (3), p.327-335</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-563e26baffbb4c6df6061c5c4d1f9fa848a83dfa705b0cc7b0a6e74189873dcf3</citedby><cites>FETCH-LOGICAL-c474t-563e26baffbb4c6df6061c5c4d1f9fa848a83dfa705b0cc7b0a6e74189873dcf3</cites><orcidid>0000-0003-0469-2801</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12022-021-09683-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12022-021-09683-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34019236$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boyraz, Baris</creatorcontrib><creatorcontrib>Sadow, Peter M.</creatorcontrib><creatorcontrib>Asa, Sylvia L.</creatorcontrib><creatorcontrib>Dias-Santagata, Dora</creatorcontrib><creatorcontrib>Nosé, Vania</creatorcontrib><creatorcontrib>Mete, Ozgur</creatorcontrib><title>Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis</title><title>Endocrine pathology</title><addtitle>Endocr Pathol</addtitle><addtitle>Endocr Pathol</addtitle><description>Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest case series, consisting of 33 tumors. The age at time of pathological diagnosis ranged from 18 to 59 (mean 33) years, and all patients except one were female. Sixteen patients had multifocal and fifteen had unifocal disease. The status of focality was unavailable in two patients. Tumors were well-circumscribed, ranging in size from 0.1 to 8.0 cm. The cribriform component was admixed with morulae in the majority, except seven had a cribriform-predominant architecture and two had predominantly solid growth. Variable degrees of nuclear enlargement, elongation, overlapping, and grooves were seen but florid nuclear convolution, intranuclear pseudoinclusions, and optically clear nuclei due to chromatin margination were not appreciated. There was no or little colloid material within the cribriform spaces. Two solid tumors had high-grade features. Immunohistochemical studies showed beta-catenin nuclear and cytoplasmic positivity in all cases. The cribriform component was positive for TTF1 and negative for thyroglobulin. PAX8 was absent in half of these tumors and focal in the remainder. Morulae were positive for keratin 5 and CD5 and negative for p63, p40, TTF1, and PAX8. Molecular studies revealed germline
APC
mutations in 12 tumors and were negative in 5 sporadic tumors in a subset of tested tumors. Irrespective of the antibody used in this cohort, all cribriform-morular carcinomas express TTF1; however, PAX8 immunoreactivity is weak, focal or negative, and all tumors lack thyroglobulin reactivity; these findings raise questions about tumor cell origin and may indicate that these are not of thyroid follicular epithelial differentiation. We postulate that morulae may represent divergent thymic/ultimobranchial pouch-related differentiation. Given their unique cytomorphology, immunohistochemical profiles, and genetic features that have little overlap with traditional follicular cell-derived thyroid carcinomas, we propose that these tumors represent a distinct form of thyroid carcinoma unrelated to other neoplasms of thyroid follicular cells.</description><subject>Adenocarcinoma - pathology</subject><subject>Adenomatous polyposis coli</subject><subject>Adolescent</subject><subject>Adult</subject><subject>CD5 antigen</subject><subject>Chromatin</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoreactivity</subject><subject>Keratin</subject><subject>Male</subject><subject>Malignancy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neoplasia</subject><subject>Oncology</subject><subject>Papillary thyroid carcinoma</subject><subject>Pathology</subject><subject>Pax8 protein</subject><subject>Solid tumors</subject><subject>Thymus</subject><subject>Thyrocytes</subject><subject>Thyroglobulin</subject><subject>Thyroid</subject><subject>Thyroid cancer</subject><subject>Thyroid Neoplasms - pathology</subject><subject>Tumors</subject><subject>Young Adult</subject><subject>β-Catenin</subject><issn>1046-3976</issn><issn>1559-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc1u1TAQhS0Eoj_wAixQJDZsDGM7sZMNEgoUKrXqpt1iTRz71lViFztBum-Pyy0X2kVXY-l8c2bGh5A3DD4wAPUxMw6cU-CMQidbQeEZOWRN01GATj0vb6glFZ2SB-Qo5xsAJgD4S3IgamAdF_KQ_OiTH5J3Mc30PKZ1wlRdXm9T9GPVYzI-xBmr01xh9cXnxQez7PVznPwmYDDbKrrqKhibFvSh6rdL3Nhgs8-vyAuHU7av7-sxuTr5etl_p2cX3077z2fU1KpeaCOF5XJA54ahNnJ0EiQzjalH5jqHbd1iK0aHCpoBjFEDoLSqZm3XKjEaJ47Jp53v7TrMdjQ2LAknfZv8jGmrI3r9UAn-Wm_iL92JRkjWFIP39wYp_lxtXvTss7HThMHGNWveCMbLd6s79N0j9CauKZTzCiU5qBaYLBTfUSbFnJN1-2UY6Lv49C4-XeLTf-LTUJre_n_GvuVvXgUQOyAXKWxs-jf7CdvfxRCnaQ</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Boyraz, Baris</creator><creator>Sadow, Peter M.</creator><creator>Asa, Sylvia L.</creator><creator>Dias-Santagata, Dora</creator><creator>Nosé, Vania</creator><creator>Mete, Ozgur</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0469-2801</orcidid></search><sort><creationdate>20210901</creationdate><title>Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis</title><author>Boyraz, Baris ; Sadow, Peter M. ; Asa, Sylvia L. ; Dias-Santagata, Dora ; Nosé, Vania ; Mete, Ozgur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-563e26baffbb4c6df6061c5c4d1f9fa848a83dfa705b0cc7b0a6e74189873dcf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Adenomatous polyposis coli</topic><topic>Adolescent</topic><topic>Adult</topic><topic>CD5 antigen</topic><topic>Chromatin</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoreactivity</topic><topic>Keratin</topic><topic>Male</topic><topic>Malignancy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neoplasia</topic><topic>Oncology</topic><topic>Papillary thyroid carcinoma</topic><topic>Pathology</topic><topic>Pax8 protein</topic><topic>Solid tumors</topic><topic>Thymus</topic><topic>Thyrocytes</topic><topic>Thyroglobulin</topic><topic>Thyroid</topic><topic>Thyroid cancer</topic><topic>Thyroid Neoplasms - pathology</topic><topic>Tumors</topic><topic>Young Adult</topic><topic>β-Catenin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boyraz, Baris</creatorcontrib><creatorcontrib>Sadow, Peter M.</creatorcontrib><creatorcontrib>Asa, Sylvia L.</creatorcontrib><creatorcontrib>Dias-Santagata, Dora</creatorcontrib><creatorcontrib>Nosé, Vania</creatorcontrib><creatorcontrib>Mete, Ozgur</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrine pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boyraz, Baris</au><au>Sadow, Peter M.</au><au>Asa, Sylvia L.</au><au>Dias-Santagata, Dora</au><au>Nosé, Vania</au><au>Mete, Ozgur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis</atitle><jtitle>Endocrine pathology</jtitle><stitle>Endocr Pathol</stitle><addtitle>Endocr Pathol</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>32</volume><issue>3</issue><spage>327</spage><epage>335</epage><pages>327-335</pages><issn>1046-3976</issn><eissn>1559-0097</eissn><abstract>Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest case series, consisting of 33 tumors. The age at time of pathological diagnosis ranged from 18 to 59 (mean 33) years, and all patients except one were female. Sixteen patients had multifocal and fifteen had unifocal disease. The status of focality was unavailable in two patients. Tumors were well-circumscribed, ranging in size from 0.1 to 8.0 cm. The cribriform component was admixed with morulae in the majority, except seven had a cribriform-predominant architecture and two had predominantly solid growth. Variable degrees of nuclear enlargement, elongation, overlapping, and grooves were seen but florid nuclear convolution, intranuclear pseudoinclusions, and optically clear nuclei due to chromatin margination were not appreciated. There was no or little colloid material within the cribriform spaces. Two solid tumors had high-grade features. Immunohistochemical studies showed beta-catenin nuclear and cytoplasmic positivity in all cases. The cribriform component was positive for TTF1 and negative for thyroglobulin. PAX8 was absent in half of these tumors and focal in the remainder. Morulae were positive for keratin 5 and CD5 and negative for p63, p40, TTF1, and PAX8. Molecular studies revealed germline
APC
mutations in 12 tumors and were negative in 5 sporadic tumors in a subset of tested tumors. Irrespective of the antibody used in this cohort, all cribriform-morular carcinomas express TTF1; however, PAX8 immunoreactivity is weak, focal or negative, and all tumors lack thyroglobulin reactivity; these findings raise questions about tumor cell origin and may indicate that these are not of thyroid follicular epithelial differentiation. We postulate that morulae may represent divergent thymic/ultimobranchial pouch-related differentiation. Given their unique cytomorphology, immunohistochemical profiles, and genetic features that have little overlap with traditional follicular cell-derived thyroid carcinomas, we propose that these tumors represent a distinct form of thyroid carcinoma unrelated to other neoplasms of thyroid follicular cells.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>34019236</pmid><doi>10.1007/s12022-021-09683-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0469-2801</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1046-3976 |
ispartof | Endocrine pathology, 2021-09, Vol.32 (3), p.327-335 |
issn | 1046-3976 1559-0097 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9353615 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adenocarcinoma - pathology Adenomatous polyposis coli Adolescent Adult CD5 antigen Chromatin Endocrinology Female Humans Immunoreactivity Keratin Male Malignancy Medicine Medicine & Public Health Middle Aged Neoplasia Oncology Papillary thyroid carcinoma Pathology Pax8 protein Solid tumors Thymus Thyrocytes Thyroglobulin Thyroid Thyroid cancer Thyroid Neoplasms - pathology Tumors Young Adult β-Catenin |
title | Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A55%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cribriform-Morular%20Thyroid%20Carcinoma%20Is%20a%20Distinct%20Thyroid%20Malignancy%20of%20Uncertain%20Cytogenesis&rft.jtitle=Endocrine%20pathology&rft.au=Boyraz,%20Baris&rft.date=2021-09-01&rft.volume=32&rft.issue=3&rft.spage=327&rft.epage=335&rft.pages=327-335&rft.issn=1046-3976&rft.eissn=1559-0097&rft_id=info:doi/10.1007/s12022-021-09683-0&rft_dat=%3Cproquest_pubme%3E2562078016%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2562078016&rft_id=info:pmid/34019236&rfr_iscdi=true |